speb/financial-data huggingface dataset:
Financial ratios for 9629.T — annual report dated 2024-03-31
Total revenue: 99167987.32171157
Gross profit: 63629160.06339144
Operating income: 15306391.970417326
Net income: 10855784.469096672
Capital expenditures: 1129160.0633914422
Operating cash flow: 22820919.17591125
Depreciation & amortization: 1413100.8980454307
Net tangible assets: 123032223.98309562
Owner earnings: 11139725.30375066
Return on net tangible assets (%): 9.054315156719623
Capex to operating income (%): 7.377049180327869
Buffett classification: The Great
Stock price: 10.30784469096672
P/E ratio: 19.03982076010949
Shares outstanding: 20051931
Book value: 125198098.25673534
P/B ratio: 1.6509211671740507
Market cap (USD): 206692190.501981
Debt to equity: 0
Current ratio: 2.0152671755725193
Quick ratio: 1.9926779872254246
Effective tax rate (%): 29.79086641058472
COGS to revenue (%): 35.83699560527368
R&D to revenue (%): 6.1259821547476365
SG&A to revenue (%): 11.066719936076709
Free cash flow (dilution-adjusted): 21335182.250396196
Buyback yield (%): 0
Retained earnings: 105249603.80348653
Inventory turnover: 18.558620689655175
Receivables turnover: 4.885491216655822
Capitalized R&D asset: 10298420.136099242
ROCI (R&D-adjusted, %): 11.33389479400072
Rosenberg metric: 0.6896308270801259
FCF margin (%): 21.51418298042349
Revenue growth (%): 1.7575567114372364
Rule of 40 score: 23.271739691860727
Financial ratios for 9629.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 128549509.73525704
Buffett classification: The Gruesome
Stock price: 13.018560022412101
Shares outstanding: 20051931
Book value: 131316739.03908111
P/B ratio: 1.9879207266262968
Market cap (USD): 261047267.2887659
Debt to equity: 0
Current ratio: 1.9527897730907906
Quick ratio: 1.933454848538762
Buyback yield (%): 0
Retained earnings: 106674744.36195545
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9629.T — annual report dated 2025-03-31
Total revenue: 108521588.02299158
Gross profit: 68359844.94051597
Operating income: 17658067.103328433
Net income: 11883438.043042373
Capital expenditures: 1243149.3115893598
Operating cash flow: 19068306.37615292
Depreciation & amortization: 1644165.2185536693
Net tangible assets: 126620772.62398075
Owner earnings: 12284453.950006682
Return on net tangible assets (%): 9.70176827659013
Capex to operating income (%): 7.040121120363361
Buffett classification: The Great
Stock price: 11.083344472664082
P/E ratio: 18.701865386946007
Shares outstanding: 20051931
Book value: 128866461.70298089
P/B ratio: 1.7245950240127588
Market cap (USD): 222242458.61509156
Debt to equity: 0
Current ratio: 1.8864934323243863
Quick ratio: 1.8707881210736723
Effective tax rate (%): 33.22072072072072
COGS to revenue (%): 37.00806799285582
R&D to revenue (%): 4.514380735357516
SG&A to revenue (%): 12.336022664285275
Free cash flow (dilution-adjusted): 17083277.636679586
Buyback yield (%): 0
Retained earnings: 107325223.90054806
Inventory turnover: 27.313636363636363
Receivables turnover: 5.840647482014389
Capitalized R&D asset: 10490557.232523505
ROCI (R&D-adjusted, %): 11.527457661624771
Rosenberg metric: 0.7787118671649328
FCF margin (%): 15.741824228613657
Revenue growth (%): 9.432076775881242
Rule of 40 score: 25.1739010044949
Financial ratios for 9629.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 126620772.62398075
Buffett classification: The Gruesome
Stock price: 11.083344472664082
Shares outstanding: 20051931
Book value: 128866461.70298089
P/B ratio: 1.7245950240127588
Market cap (USD): 222242458.61509156
Debt to equity: 0
Current ratio: 1.8864934323243863
Quick ratio: 1.8707881210736723
Buyback yield (%): 0
Retained earnings: 107325223.90054806
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9629.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.788472183780792
Shares outstanding: 20051931
Market cap (USD): 236381630.82459176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9629.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 118990578.73485869
Buffett classification: The Gruesome
Stock price: 12.711843876177658
Shares outstanding: 20051931
Book value: 122032301.48048455
P/B ratio: 2.088766770727914
Market cap (USD): 254897016.28788695
Debt to equity: 0
Current ratio: 1.819713370940692
Quick ratio: 1.8012654368043908
Buyback yield (%): 0
Retained earnings: 101433378.19650067
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9979.T — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.606512643259961
Shares outstanding: 20985074
Market cap (USD): 180608304.70074588
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9979.T — annual report dated 2022-08-31
Total revenue: 258048006.9199164
Gross profit: 113255964.8237584
Operating income: -38794781.229726814
Net income: -5550349.599942334
Capital expenditures: 3878036.473725943
Operating cash flow: 24479204.2096158
Depreciation & amortization: 8830101.636271896
Net tangible assets: 58451668.709003106
Owner earnings: -598284.437396381
Return on net tangible assets (%): -1.0235540757183368
Buffett classification: The Gruesome
Stock price: 7.948605204353782
Shares outstanding: 20985074
Book value: 72543790.09586969
P/B ratio: 2.2993293869773446
Market cap (USD): 166802068.41014922
Debt to equity: 1.5200715421303654
Current ratio: 1.4489867635000586
Quick ratio: 1.3712076841981964
Interest coverage ratio: -65.63414634146342
COGS to revenue (%): 56.11050588005252
SG&A to revenue (%): 4.343696751305902
Free cash flow (dilution-adjusted): 18799106.177467022
Buyback yield (%): 0
Retained earnings: 3813162.2576227207
Inventory turnover: 30.251506024096386
Receivables turnover: 17.16155321188878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.356295385103767
FCF margin (%): 7.285119696080895
Rule of 40 score: 7.285119696080895
Financial ratios for 9979.T — annual report dated 2023-08-31
Total revenue: 311396303.9014374
Gross profit: 126228610.54072553
Operating income: -3100616.016427105
Net income: -5263518.138261465
Capital expenditures: 8097193.70294319
Operating cash flow: 5366187.5427789185
Depreciation & amortization: 7713894.592744696
Net tangible assets: 51266255.9890486
Owner earnings: -5646817.248459959
Return on net tangible assets (%): -11.014686248331108
Buffett classification: The Gruesome
Stock price: 7.548459958932238
Shares outstanding: 20985074
Book value: 64914442.16290212
P/B ratio: 2.4402118472606493
Market cap (USD): 158404990.82423
Debt to equity: 1.5554618304512864
Current ratio: 1.3598572328364475
Quick ratio: 1.2461683812723072
Interest coverage ratio: -5.457831325301204
COGS to revenue (%): 59.46367732717881
SG&A to revenue (%): 3.593801516650181
Free cash flow (dilution-adjusted): -3162217.6591375773
Buyback yield (%): 0
Retained earnings: 3963039.014373717
Inventory turnover: 24.979686057248383
Receivables turnover: 14.761518494484102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9144620065928493
FCF margin (%): -1.0154962083745467
Revenue growth (%): 20.67378764838797
Rule of 40 score: 19.658291440013425
Financial ratios for 9979.T — annual report dated 2024-08-31
Total revenue: 349133825.6608462
Gross profit: 135627027.40009663
Operating income: 6970805.4386086
Net income: 9206984.609013736
Capital expenditures: 1090482.4349506523
Operating cash flow: 10601145.696735455
Depreciation & amortization: 7315894.816757541
Net tangible assets: 58099247.70515564
Owner earnings: 15432396.990820626
Return on net tangible assets (%): 26.56212877167974
Capex to operating income (%): 15.643564356435643
Buffett classification: The Great
Stock price: 7.463938159983437
P/E ratio: 17.012225095427286
Shares outstanding: 20985074
Book value: 71785492.44254261
P/B ratio: 2.1819352251995006
Market cap (USD): 156631294.61867628
Debt to equity: 1.3443899625036055
Current ratio: 1.1310168704534902
Quick ratio: 1.0461228911933136
Effective tax rate (%): -6.810897435897437
Interest coverage ratio: 10.30612244897959
COGS to revenue (%): 61.15328351717867
SG&A to revenue (%): 2.8308227572846243
Free cash flow (dilution-adjusted): 4713920.905514529
Buyback yield (%): 0
Retained earnings: 19808130.30574919
Inventory turnover: 28.199635369188695
Receivables turnover: 13.007456929802006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9024366566352775
FCF margin (%): 1.3501759380065632
Revenue growth (%): 12.118808504340302
Rule of 40 score: 13.468984442346866
Financial ratios for 9979.T — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.763643580075413
Shares outstanding: 20985074
Market cap (USD): 141935561.03750747
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9979.T — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 59869342.04386374
Buffett classification: The Gruesome
Stock price: 6.867008866075595
Shares outstanding: 20985074
Book value: 72988467.43550432
P/B ratio: 1.9743487468152339
Market cap (USD): 144104689.21325245
Debt to equity: 0.8933235911955428
Current ratio: 1.1697973044677914
Quick ratio: 1.0526371643850152
Buyback yield (%): 0
Retained earnings: 22738484.101059932
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9979.T — annual report dated 2025-08-31
Total revenue: 358035288.5073915
Gross profit: 138565297.36358064
Operating income: 8202193.609918932
Net income: 7991007.561823013
Capital expenditures: 3086041.283466176
Operating cash flow: 14633149.397097895
Depreciation & amortization: 7159888.275768105
Net tangible assets: 63096941.2085292
Owner earnings: 12064854.554124944
Return on net tangible assets (%): 19.121140142517817
Capex to operating income (%): 37.624584717607966
Buffett classification: The Good
Stock price: 8.079501328428368
P/E ratio: 21.217466251713553
Shares outstanding: 20985074
Book value: 76878533.96007903
P/B ratio: 2.2054131956809924
Market cap (USD): 169548933.2601676
Debt to equity: 0.7808595480726628
Current ratio: 1.085222978080121
Quick ratio: 0.9789304610733182
Effective tax rate (%): 12.05992509363296
Interest coverage ratio: 10.56140350877193
COGS to revenue (%): 61.29842453763605
SG&A to revenue (%): 2.9530405662531396
Free cash flow (dilution-adjusted): 8706315.144083384
Buyback yield (%): 0
Retained earnings: 25539886.913277473
Inventory turnover: 28.636444444444447
Receivables turnover: 12.719264278799614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.3572522308464015
FCF margin (%): 2.43169190958216
Revenue growth (%): 2.5495847701655676
Rule of 40 score: 4.981276679747728
Financial ratios for 9979.T — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 63096941.2085292
Buffett classification: The Gruesome
Stock price: 8.079501328428368
Shares outstanding: 20985074
Book value: 76878533.96007903
P/B ratio: 2.2054131956809924
Market cap (USD): 169548933.2601676
Debt to equity: 0.7808595480726628
Current ratio: 1.085222978080121
Quick ratio: 0.9789304610733182
Buyback yield (%): 0
Retained earnings: 25539886.913277473
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9979.T — quarterly report dated 2025-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.315139493217303
Shares outstanding: 20985074
Market cap (USD): 153508743.5854876
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9983.HK — annual report dated 2021-12-31
Total revenue: 564979277.8649921
Gross profit: 185749136.577708
Operating income: 146151177.39403453
Net income: 102572684.45839874
Capital expenditures: 4438618.52433281
Operating cash flow: 28012401.883830454
Depreciation & amortization: 9094348.508634223
Net tangible assets: 420753532.1821036
Owner earnings: 107228414.44270016
Return on net tangible assets (%): 25.48485187672562
Capex to operating income (%): 3.0370049721638313
Buffett classification: The Great
Stock price: 0.3474358974358974
P/E ratio: 4.366250885640181
Shares outstanding: 1289038000
Book value: 479831711.1459968
P/B ratio: 0.9333648943070918
Market cap (USD): 447858074.35897434
Debt to equity: 0.016418302073463748
Current ratio: 2.512500938385473
Quick ratio: 2.502877624123055
Effective tax rate (%): 20.90250758424994
Interest coverage ratio: 269.61569649580076
COGS to revenue (%): 67.1228408093766
SG&A to revenue (%): 7.9678947950467345
Free cash flow (dilution-adjusted): 22485714.285714284
Buyback yield (%): 0.28543327070617663
Retained earnings: 186594348.5086342
Inventory turnover: 137.5524427741715
Receivables turnover: 1.6197151594661434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.984192896906237
FCF margin (%): 3.9799184088106476
Rule of 40 score: 3.9799184088106476
Financial ratios for 9983.HK — annual report dated 2022-12-31
Total revenue: 452319109.1954023
Gross profit: 149884482.75862068
Operating income: 114974425.28735632
Net income: 82063793.10344827
Capital expenditures: 2104166.6666666665
Operating cash flow: 44348275.862068966
Depreciation & amortization: 8777298.850574713
Net tangible assets: 383833764.3678161
Owner earnings: 88736925.28735632
Return on net tangible assets (%): 23.118582450272
Capex to operating income (%): 1.8301171424929583
Buffett classification: The Great
Stock price: 0.2464698331193838
P/E ratio: 3.871487884359007
Shares outstanding: 1289038000
Book value: 439528591.95402294
P/B ratio: 0.7228403033625133
Market cap (USD): 317708980.74454427
Debt to equity: 0.02804696384808829
Current ratio: 2.2739772734229784
Quick ratio: 2.2671703202903624
Effective tax rate (%): 24.76566822097526
Interest coverage ratio: 77.33855223736349
COGS to revenue (%): 66.8631106421218
SG&A to revenue (%): 8.605713657679246
Free cash flow (dilution-adjusted): 41680172.4137931
Buyback yield (%): 0.6355668224521517
Retained earnings: 243268390.8045977
Inventory turnover: 145.6306212813062
Receivables turnover: 1.1622370362658567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.91823636548773
FCF margin (%): 9.214771511187077
Revenue growth (%): -19.940584209623204
Rule of 40 score: -10.725812698436126
Financial ratios for 9983.HK — annual report dated 2023-12-31
Total revenue: 400092123.76933897
Gross profit: 106482700.42194092
Operating income: 78149648.38255978
Net income: -80783263.00984529
Capital expenditures: 1719268.635724332
Operating cash flow: -10842194.092827003
Depreciation & amortization: 6866666.666666666
Net tangible assets: 253571026.72292545
Owner earnings: -75635864.97890295
Return on net tangible assets (%): -29.8282757128832
Capex to operating income (%): 2.1999697648134418
Buffett classification: The Great
Stock price: 0.1382842509603073
Shares outstanding: 1289038000
Book value: 304127848.1012658
P/B ratio: 0.5861142128293996
Market cap (USD): 178253654.2893726
Debt to equity: 0.03137513879581881
Current ratio: 1.631464537667882
Quick ratio: 1.6264875402510892
Interest coverage ratio: 89.62
COGS to revenue (%): 73.38545447514726
SG&A to revenue (%): 7.5825363708428615
Free cash flow (dilution-adjusted): -14607172.99578059
Buyback yield (%): 0.2314216684738145
Retained earnings: 152551054.85232067
Inventory turnover: 164.4916082263021
Receivables turnover: 1.1535544939134004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.14639308136334
FCF margin (%): -3.650952400203188
Revenue growth (%): -11.54649104234534
Rule of 40 score: -15.197443442548527
Financial ratios for 9983.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 223447671.23287672
Buffett classification: The Gruesome
Stock price: 0.14304123711340208
Shares outstanding: 1289038000
Book value: 272516849.31506854
P/B ratio: 0.6766025318053248
Market cap (USD): 184385590.20618558
Debt to equity: 0.03365884627970722
Current ratio: 1.5712900915887793
Quick ratio: 1.5668931891594409
Buyback yield (%): 0
Retained earnings: 173528630.13698632
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9983.HK — annual report dated 2024-12-31
Total revenue: 404414657.53424656
Gross profit: 87772328.7671233
Operating income: 60247808.21917808
Net income: 32626301.369863015
Capital expenditures: 502739.72602739726
Operating cash flow: 528219.1780821919
Depreciation & amortization: 5981917.808219179
Net tangible assets: 223447671.23287672
Owner earnings: 38105479.45205479
Return on net tangible assets (%): 17.05342429473849
Capex to operating income (%): 0.8344531376120089
Buffett classification: The Great
Stock price: 0.14304123711340208
P/E ratio: 5.651440171410387
Shares outstanding: 1289038000
Book value: 272516849.31506854
P/B ratio: 0.6766025318053248
Market cap (USD): 184385590.20618558
Debt to equity: 0.03365884627970722
Current ratio: 1.5712900915887793
Quick ratio: 1.5668931891594409
Effective tax rate (%): 33.64407086598817
Interest coverage ratio: 90.29131595154998
COGS to revenue (%): 78.2964521359638
SG&A to revenue (%): 6.884531575654583
Free cash flow (dilution-adjusted): -2787671.2328767125
Buyback yield (%): 0
Retained earnings: 173528630.13698632
Inventory turnover: 205.48395412925592
Receivables turnover: 1.056334964109915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.281070143490933
FCF margin (%): -0.6893101377366985
Revenue growth (%): 1.0803846184684267
Rule of 40 score: 0.39107448073172824
Financial ratios for 9983.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 232281450.48814505
Buffett classification: The Gruesome
Stock price: 0.135031847133758
Shares outstanding: 1289038000
Book value: 280970990.23709905
P/B ratio: 0.6194987675372556
Market cap (USD): 174061182.16560513
Debt to equity: 0.032435834687639296
Current ratio: 1.6266350874724573
Quick ratio: 1.6238862384715531
Buyback yield (%): 0
Retained earnings: 191481868.8981869
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALAB — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 849000
Buffett classification: The Gruesome
Stock price: 52.39
Shares outstanding: 171407939
Market cap (USD): 8980061924.210001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALAB — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 974000
Buffett classification: The Gruesome
Stock price: 132.45
Shares outstanding: 171407939
Market cap (USD): 22702981520.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALAB — annual report dated 2024-12-31
Total revenue: 396290000
Gross profit: 302699000
Operating income: -116066000
Net income: -83421000
Capital expenditures: 34245000
Operating cash flow: 136676000
Depreciation & amortization: 3154000
Net tangible assets: 964799000
Owner earnings: -114512000
Return on net tangible assets (%): -11.86900069340868
Buffett classification: The Gruesome
Stock price: 132.45
Shares outstanding: 171407939
Book value: 964799000
P/B ratio: 23.531307060382524
Market cap (USD): 22702981520.55
Debt to equity: 0.0013329201211858637
Current ratio: 11.705056504356266
Quick ratio: 11.205703589008804
COGS to revenue (%): 23.616795780867548
R&D to revenue (%): 50.67753412904691
SG&A to revenue (%): 54.99381765878524
Free cash flow (dilution-adjusted): -132157000
Buyback yield (%): 0.004695418524809578
Retained earnings: -208796000
Inventory turnover: 2.165706351961125
Receivables turnover: 10.210764989307155
Capitalized R&D asset: 274337320
ROCI (R&D-adjusted, %): -2.512966532735876
Rosenberg metric: 3.036113722124593
FCF margin (%): -33.34855787428398
Revenue growth (%): 242.23707618702178
Rule of 40 score: 208.8885183127378
Financial ratios for ALAB — quarterly report dated 2025-03-31
Total revenue: 159442000
Gross profit: 119411000
Operating income: 11285000
Net income: 31819000
Capital expenditures: 4539000
Operating cash flow: 10504000
Depreciation & amortization: 1125000
Net tangible assets: 1041562000
Owner earnings: 28405000
Return on net tangible assets (%): 2.7271540244363757
Capex to operating income (%): 40.221533008418255
Buffett classification: The Good
Stock price: 59.67
P/E ratio: 80.36009711280997
Shares outstanding: 171407939
Book value: 1041562000
P/B ratio: 9.819781943014434
Market cap (USD): 10227911720.130001
Debt to equity: 0
Current ratio: 13.9210533126294
Quick ratio: 13.26037784679089
Effective tax rate (%): -46.51655385182115
COGS to revenue (%): 25.106935437337714
R&D to revenue (%): 40.487449981811565
SG&A to revenue (%): 27.32780572245707
Free cash flow (dilution-adjusted): -36481000
Buyback yield (%): 0
Retained earnings: -176977000
Inventory turnover: 0.7840452827232309
Receivables turnover: 2.2849895382498784
Capitalized R&D asset: 64554000
ROCI (R&D-adjusted, %): 4.898337914168849
FCF margin (%): -22.88042046637649
Rule of 40 score: -22.88042046637649
Financial ratios for ALAB — quarterly report dated 2025-06-30
Total revenue: 191925000
Gross profit: 145563000
Operating income: 39774000
Net income: 51219000
Capital expenditures: 2023000
Operating cash flow: 135366000
Depreciation & amortization: 1392000
Net tangible assets: 1135714000
Owner earnings: 50588000
Return on net tangible assets (%): 4.454290428752309
Capex to operating income (%): 5.086237240408307
Buffett classification: The Great
Stock price: 90.42
P/E ratio: 186.64594335581302
Shares outstanding: 171407939
Book value: 1135714000
P/B ratio: 13.646662667167966
Market cap (USD): 15498705844.380001
Debt to equity: 0
Current ratio: 11.099028980194204
Quick ratio: 10.548170290365942
Effective tax rate (%): -1.1054304269725024
COGS to revenue (%): 24.156311059007425
R&D to revenue (%): 34.765663670704704
SG&A to revenue (%): 20.354305067083498
Free cash flow (dilution-adjusted): 97869000
Buyback yield (%): 0
Retained earnings: -125758000
Inventory turnover: 0.791133408416095
Receivables turnover: 7.892301998519615
Capitalized R&D asset: 109975180
ROCI (R&D-adjusted, %): 4.9206906219719375
Rosenberg metric: 0.40511819561917156
FCF margin (%): 50.99335677999218
Revenue growth (%): 20.37292557795311
Rule of 40 score: 71.3662823579453
Financial ratios for ALAB — quarterly report dated 2025-09-30
Total revenue: 230575000
Gross profit: 175812000
Operating income: 55406000
Net income: 91114000
Capital expenditures: 12293000
Operating cash flow: 78171000
Depreciation & amortization: 1466000
Net tangible assets: 1271731000
Owner earnings: 80287000
Return on net tangible assets (%): 6.3132061733180995
Capex to operating income (%): 22.18712774789734
Buffett classification: The Great
Stock price: 195.8
P/E ratio: 192.71483793582618
Shares outstanding: 171407939
Book value: 1271731000
P/B ratio: 26.390545214514706
Market cap (USD): 33561674456.2
Debt to equity: 0
Current ratio: 12.779165593613186
Quick ratio: 12.26743794449177
Effective tax rate (%): -36.271723849122075
COGS to revenue (%): 23.75062344139651
R&D to revenue (%): 34.23094437818497
SG&A to revenue (%): 17.98894069174889
Free cash flow (dilution-adjusted): 25139000
Buyback yield (%): 0
Retained earnings: -34644000
Inventory turnover: 1.0600042583667229
Receivables turnover: 5.374959205557369
Capitalized R&D asset: 144935900
ROCI (R&D-adjusted, %): 4.446935825809541
Rosenberg metric: 0.4533451231940531
FCF margin (%): 10.902743142144638
Revenue growth (%): 20.138074768789892
Rule of 40 score: 31.04081791093453
Financial ratios for ALAB — annual report dated 2025-12-31
Total revenue: 852525000
Gross profit: 645261000
Operating income: 173423000
Net income: 219134000
Capital expenditures: 37544000
Operating cash flow: 319306000
Depreciation & amortization: 6829000
Net tangible assets: 1363634000
Owner earnings: 188419000
Return on net tangible assets (%): 13.817417283523293
Capex to operating income (%): 21.64880090876066
Buffett classification: The Great
Stock price: 166.36
P/E ratio: 130.1277972931631
Shares outstanding: 171407939
Book value: 1363634000
P/B ratio: 20.91134771649871
Market cap (USD): 28515424732.04
Debt to equity: 0.0030404052700358014
Current ratio: 10.237594143202898
Quick ratio: 9.794283008373295
Effective tax rate (%): -0.4496843958139471
COGS to revenue (%): 24.311779713204892
R&D to revenue (%): 35.6585437377203
SG&A to revenue (%): 19.6873991965045
Free cash flow (dilution-adjusted): 121729000
Buyback yield (%): 0
Retained earnings: 10338000
Inventory turnover: 3.5141999694806625
Receivables turnover: 10.246448402682628
Capitalized R&D asset: 462778410
ROCI (R&D-adjusted, %): 15.292340307312566
Rosenberg metric: 1.7057312154558582
FCF margin (%): 14.27864285504824
Revenue growth (%): 115.12654873955941
Rule of 40 score: 129.40519159460766
Financial ratios for ALAB — quarterly report dated 2025-12-31
Total revenue: 270583000
Gross profit: 204475000
Operating income: 66958000
Net income: 44982000
Capital expenditures: 18689000
Operating cash flow: 95265000
Depreciation & amortization: 2846000
Net tangible assets: 1363634000
Owner earnings: 29139000
Return on net tangible assets (%): 2.136863703897087
Capex to operating income (%): 27.911526628632878
Buffett classification: The Good
Stock price: 166.36
P/E ratio: 130.1277972931631
Shares outstanding: 171407939
Book value: 1363634000
P/B ratio: 20.91134771649871
Market cap (USD): 28515424732.04
Debt to equity: 0.0030404052700358014
Current ratio: 10.237594143202898
Quick ratio: 9.794283008373295
Effective tax rate (%): 42.999429766204145
COGS to revenue (%): 24.431690091395247
R&D to revenue (%): 34.66293152193597
SG&A to revenue (%): 16.159551782632317
Free cash flow (dilution-adjusted): 35202000
Buyback yield (%): 0
Retained earnings: 10338000
Inventory turnover: 1.120873531256888
Receivables turnover: 3.2521213432369414
Capitalized R&D asset: 168692680
ROCI (R&D-adjusted, %): 5.163425349083585
Rosenberg metric: 0.3631537603892155
FCF margin (%): 13.009686491760384
Revenue growth (%): 17.351404098449528
Rule of 40 score: 30.361090590209912
Financial ratios for AMKR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.28
Shares outstanding: 247872518
Market cap (USD): 5770472219.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMKR — annual report dated 2022-12-31
Total revenue: 7091585000
Gross profit: 1329987000
Operating income: 897186000
Net income: 767042000
Capital expenditures: 905146000
Operating cash flow: 1098756000
Depreciation & amortization: 612702000
Net tangible assets: 3647235000
Owner earnings: 474598000
Return on net tangible assets (%): 13.012542377993192
Capex to operating income (%): 100.8872184808947
Buffett classification: The Gruesome
Stock price: 22.75
P/E ratio: 7.3517483847038365
Shares outstanding: 247872518
Book value: 3699701000
P/B ratio: 1.5242041950146783
Market cap (USD): 5639099784.5
Debt to equity: 0.3880421688131014
Current ratio: 1.9858139774099184
Quick ratio: 1.6071013726449115
Effective tax rate (%): 10.489747144464205
Interest coverage ratio: 15.320014343527482
COGS to revenue (%): 81.24556075968913
R&D to revenue (%): 2.1071311984556345
SG&A to revenue (%): 3.9958909045016027
Free cash flow (dilution-adjusted): 176900000
Buyback yield (%): 0
Retained earnings: 1874644000
Inventory turnover: 9.151552791084793
Receivables turnover: 5.193382809570679
Capitalized R&D asset: 149429000
ROCI (R&D-adjusted, %): 18.776560192009143
FCF margin (%): 2.49450581217034
Rule of 40 score: 2.49450581217034
Financial ratios for AMKR — annual report dated 2023-12-31
Total revenue: 6503065000
Gross profit: 943153000
Operating income: 470287000
Net income: 362131000
Capital expenditures: 741023000
Operating cash flow: 1270020000
Depreciation & amortization: 631508000
Net tangible assets: 3942305000
Owner earnings: 252616000
Return on net tangible assets (%): 6.4078248638803945
Capex to operating income (%): 157.56825087659237
Buffett classification: The Gruesome
Stock price: 31.92
P/E ratio: 21.84869777666093
Shares outstanding: 247872518
Book value: 3995035000
P/B ratio: 1.980480965638599
Market cap (USD): 7912090774.56
Debt to equity: 0.3383374613739304
Current ratio: 2.308319037902454
Quick ratio: 2.024364470286571
Effective tax rate (%): 18.409745832403946
Interest coverage ratio: 7.970966101694915
COGS to revenue (%): 85.49679266622738
R&D to revenue (%): 2.7290669861057824
SG&A to revenue (%): 4.542365792130326
Free cash flow (dilution-adjusted): 512276000
Buyback yield (%): 0
Retained earnings: 2159831000
Inventory turnover: 14.142752487739362
Receivables turnover: 5.657333276496682
Capitalized R&D asset: 277590430
ROCI (R&D-adjusted, %): 9.512178611151691
Rosenberg metric: -2.588747833419216
FCF margin (%): 7.8774547078954305
Revenue growth (%): -8.298849975005588
Rule of 40 score: -0.4213952671101575
Financial ratios for AMKR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.57
Shares outstanding: 247872518
Market cap (USD): 7329590357.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMKR — annual report dated 2024-12-31
Total revenue: 6317692000
Gross profit: 933212000
Operating income: 438455000
Net income: 355535000
Capital expenditures: 739815000
Operating cash flow: 1088868000
Depreciation & amortization: 594663000
Net tangible assets: 4131598000
Owner earnings: 210383000
Return on net tangible assets (%): 5.092049129658791
Capex to operating income (%): 168.7322530248258
Buffett classification: The Gruesome
Stock price: 25.28
P/E ratio: 17.62475496094618
Shares outstanding: 247872518
Book value: 4183165000
P/B ratio: 1.4979608155642918
Market cap (USD): 6266217255.04
Debt to equity: 0.3107415079252193
Current ratio: 2.111952723712013
Quick ratio: 1.8983092542646578
Effective tax rate (%): 17.512342929264808
Interest coverage ratio: 6.751174070367234
COGS to revenue (%): 85.22859297350995
R&D to revenue (%): 2.5792805347269225
SG&A to revenue (%): 5.2520129186418085
Free cash flow (dilution-adjusted): 326701000
Buyback yield (%): 0
Retained earnings: 2335132000
Inventory turnover: 17.318452285227234
Receivables turnover: 5.988259860305039
Capitalized R&D asset: 331169480
ROCI (R&D-adjusted, %): 7.527575933259971
Rosenberg metric: -0.05601415426571929
FCF margin (%): 5.171208093082094
Revenue growth (%): -2.850548164596233
Rule of 40 score: 2.320659928485861
Financial ratios for AMKR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.28
Shares outstanding: 247872518
Market cap (USD): 6266217255.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMKR — quarterly report dated 2025-03-31
Total revenue: 1321575000
Gross profit: 157583000
Operating income: 31523000
Net income: 21853000
Capital expenditures: 75688000
Operating cash flow: 24149000
Depreciation & amortization: 153821000
Net tangible assets: 4137597000
Owner earnings: 99986000
Return on net tangible assets (%): 2.4165234071853785
Capex to operating income (%): 240.1040510103734
Buffett classification: The Gruesome
Stock price: 17.85
P/E ratio: 50.61689981123874
Shares outstanding: 247872518
Book value: 4190590000
P/B ratio: 1.0558237494720315
Market cap (USD): 4424524446.3
Debt to equity: 0.3061428104395801
Current ratio: 2.0572031450312798
Quick ratio: 1.8328631284147743
Effective tax rate (%): 15.262321144674084
Interest coverage ratio: 1.875364388125409
COGS to revenue (%): 88.07612129466735
R&D to revenue (%): 3.4543631651627793
SG&A to revenue (%): 6.084255528441443
Free cash flow (dilution-adjusted): -55748000
Buyback yield (%): 0
Retained earnings: 2335830000
Inventory turnover: 3.568502536903904
Receivables turnover: 1.2552083679608081
Capitalized R&D asset: 45652000
ROCI (R&D-adjusted, %): 1.1238635855875694
FCF margin (%): -4.218300134309441
Rule of 40 score: -4.218300134309441
Financial ratios for AMKR — quarterly report dated 2025-06-30
Total revenue: 1511392000
Gross profit: 181897000
Operating income: 91967000
Net income: 55052000
Capital expenditures: 145636000
Operating cash flow: 258463000
Depreciation & amortization: 158842000
Net tangible assets: 4177836000
Owner earnings: 68258000
Return on net tangible assets (%): 1.6338123372961504
Capex to operating income (%): 158.3568018963324
Buffett classification: The Gruesome
Stock price: 20.83
P/E ratio: 67.13717638567063
Shares outstanding: 247872518
Book value: 4232074000
P/B ratio: 1.2200128234856005
Market cap (USD): 5163184549.94
Debt to equity: 0.40187293511408356
Current ratio: 1.8921098815970667
Quick ratio: 1.696225116956958
Effective tax rate (%): 33.84286297978705
Interest coverage ratio: 5.470969660916121
COGS to revenue (%): 87.96493563549363
R&D to revenue (%): 2.7794245304990364
SG&A to revenue (%): 3.1707194427388794
Free cash flow (dilution-adjusted): 112274000
Buyback yield (%): 0
Retained earnings: 2369797000
Inventory turnover: 3.5429674696001854
Receivables turnover: 1.3427601267251015
Capitalized R&D asset: 72594840
ROCI (R&D-adjusted, %): 1.7868477376339649
Rosenberg metric: 0.5325944098834662
FCF margin (%): 7.428516228748068
Revenue growth (%): 14.362938160906493
Rule of 40 score: 21.79145438965456
Financial ratios for AMKR — quarterly report dated 2025-09-30
Total revenue: 1986968000
Gross profit: 284490000
Operating income: 158927000
Net income: 126682000
Capital expenditures: 246065000
Operating cash flow: 168514000
Depreciation & amortization: 163614000
Net tangible assets: 4289290000
Owner earnings: 44231000
Return on net tangible assets (%): 1.031196305216015
Capex to operating income (%): 154.82894662329244
Buffett classification: The Gruesome
Stock price: 28.29
P/E ratio: 34.44381779887714
Shares outstanding: 247872518
Book value: 4342944000
P/B ratio: 1.6146451656341871
Market cap (USD): 7012313534.219999
Debt to equity: 0.45263949984158214
Current ratio: 1.77272087968856
Quick ratio: 1.5958543677039445
Effective tax rate (%): 17.950478312402442
Interest coverage ratio: 7.485610663652206
COGS to revenue (%): 85.68220524940511
R&D to revenue (%): 2.13148878089632
SG&A to revenue (%): 4.187837952095856
Free cash flow (dilution-adjusted): -77931000
Buyback yield (%): 0
Retained earnings: 2475936000
Inventory turnover: 4.257344483010413
Receivables turnover: 1.4198247020606727
Capitalized R&D asset: 85562520
ROCI (R&D-adjusted, %): 2.6270795777863376
Rosenberg metric: 2.4422252904208723
FCF margin (%): -3.922106445599526
Revenue growth (%): 31.466092185217338
Rule of 40 score: 27.543985739617813
Financial ratios for AMKR — quarterly report dated 2025-12-31
Total revenue: 1888046000
Gross profit: 314629000
Operating income: 184968000
Net income: 172529000
Capital expenditures: 326946000
Operating cash flow: 644480000
Depreciation & amortization: 165731000
Net tangible assets: 4453103000
Owner earnings: 11314000
Return on net tangible assets (%): 0.25407002712490595
Capex to operating income (%): 176.75814194887764
Buffett classification: The Gruesome
Stock price: 39.4
P/E ratio: 25.965864810856225
Shares outstanding: 247872518
Book value: 4506287000
P/B ratio: 2.1672337357119065
Market cap (USD): 9766177209.199999
Debt to equity: 0.3464007063908712
Current ratio: 2.269173210776812
Quick ratio: 2.0134464816013344
Effective tax rate (%): 4.795302920775415
Interest coverage ratio: 8.981645139360978
COGS to revenue (%): 83.33573440477615
R&D to revenue (%): 1.9454504816090286
SG&A to revenue (%): 4.922019908413248
Free cash flow (dilution-adjusted): 212397000
Buyback yield (%): 0
Retained earnings: 2627038000
Inventory turnover: 3.593941941127966
Receivables turnover: 1.3935718635248096
Capitalized R&D asset: 78969480
ROCI (R&D-adjusted, %): 2.788355952329858
Rosenberg metric: 0.7116310918020401
FCF margin (%): 11.249567012668123
Revenue growth (%): -4.978540167732948
Rule of 40 score: 6.271026844935175
Financial ratios for AMKR — annual report dated 2025-12-31
Total revenue: 6707981000
Gross profit: 938599000
Operating income: 467385000
Net income: 376116000
Capital expenditures: 794335000
Operating cash flow: 1095606000
Depreciation & amortization: 642008000
Net tangible assets: 4453103000
Owner earnings: 223789000
Return on net tangible assets (%): 5.025462020528158
Capex to operating income (%): 169.95303657584216
Buffett classification: The Gruesome
Stock price: 39.4
P/E ratio: 25.965864810856225
Shares outstanding: 247872518
Book value: 4506287000
P/B ratio: 2.1672337357119065
Market cap (USD): 9766177209.199999
Debt to equity: 0.3464007063908712
Current ratio: 2.269173210776812
Quick ratio: 2.0134464816013344
Effective tax rate (%): 15.407123852107086
Interest coverage ratio: 6.195124860823922
COGS to revenue (%): 86.0077272133001
R&D to revenue (%): 2.485740493301934
SG&A to revenue (%): 4.5389365294862944
Free cash flow (dilution-adjusted): 170893000
Buyback yield (%): 0
Retained earnings: 2627038000
Inventory turnover: 13.178212733298766
Receivables turnover: 4.951178934548742
Capitalized R&D asset: 334486260
ROCI (R&D-adjusted, %): 6.880966041614371
Rosenberg metric: 0.03305901774152966
FCF margin (%): 2.547607096680805
Revenue growth (%): 6.177714899681719
Rule of 40 score: 8.725321996362524
Financial ratios for AMRC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81.44
Shares outstanding: 34951417
Market cap (USD): 2846443400.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRC — annual report dated 2022-12-31
Total revenue: 1824422000
Gross profit: 290833000
Operating income: 133944000
Net income: 98549000
Capital expenditures: 327899000
Operating cash flow: -338288000
Depreciation & amortization: 54278000
Net tangible assets: 748703000
Owner earnings: -175072000
Return on net tangible assets (%): -23.38337097620819
Capex to operating income (%): 244.80305202174043
Buffett classification: The Gruesome
Stock price: 57.14
P/E ratio: 20.265289017443102
Shares outstanding: 34951417
Book value: 919654000
P/B ratio: 2.171603632866274
Market cap (USD): 1997123967.38
Debt to equity: 1.0195638794590138
Current ratio: 1.233087623203968
Quick ratio: 1.2155792372067364
Effective tax rate (%): 6.782129986095215
Interest coverage ratio: 4.372396683423647
COGS to revenue (%): 84.05889646145465
SG&A to revenue (%): 8.741837140749235
Free cash flow (dilution-adjusted): -681233000
Buyback yield (%): 0
Retained earnings: 533549000
Inventory turnover: 107.86249824166549
Receivables turnover: 2.2914836562313563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.48716819881119
FCF margin (%): -37.339661547602475
Rule of 40 score: -37.339661547602475
Financial ratios for AMRC — annual report dated 2023-12-31
Total revenue: 1374633000
Gross profit: 246429000
Operating income: 84867000
Net income: 63904000
Capital expenditures: 551767000
Operating cash flow: -69991000
Depreciation & amortization: 65911000
Net tangible assets: 819580000
Owner earnings: -421952000
Return on net tangible assets (%): -51.48393079382123
Capex to operating income (%): 650.1549483309178
Buffett classification: The Gruesome
Stock price: 31.67
P/E ratio: 17.321472464790936
Shares outstanding: 34951417
Book value: 972751000
P/B ratio: 1.1379185180894187
Market cap (USD): 1106911376.39
Debt to equity: 1.5915162256322533
Current ratio: 1.2518106517014969
Quick ratio: 1.23668315453298
Effective tax rate (%): -66.98633358593116
Interest coverage ratio: 2.1022293782511765
COGS to revenue (%): 82.07310605812606
SG&A to revenue (%): 11.795002738912858
Free cash flow (dilution-adjusted): -632076000
Buyback yield (%): 0
Retained earnings: 595911000
Inventory turnover: 82.73109921536995
Receivables turnover: 1.6579301577806027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.017702560710876
FCF margin (%): -45.98143649977849
Revenue growth (%): -24.65378075905684
Rule of 40 score: -70.63521725883533
Financial ratios for AMRC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.94
Shares outstanding: 34951417
Market cap (USD): 1326056760.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.48
Shares outstanding: 34951417
Market cap (USD): 820659271.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMRC — annual report dated 2024-12-31
Total revenue: 1769928000
Gross profit: 256091000
Operating income: 81991000
Net income: 56757000
Capital expenditures: 438346000
Operating cash flow: 117598000
Depreciation & amortization: 89211000
Net tangible assets: 938106000
Owner earnings: -292378000
Return on net tangible assets (%): -31.16684042101852
Capex to operating income (%): 534.6269712529424
Buffett classification: The Gruesome
Stock price: 23.48
P/E ratio: 14.459172809697483
Shares outstanding: 34951417
Book value: 1047612000
P/B ratio: 0.783361846905152
Market cap (USD): 820659271.16
Debt to equity: 1.6258672103794152
Current ratio: 1.4635796303295359
Quick ratio: 1.4505808721631301
Effective tax rate (%): -58.92751915144372
Interest coverage ratio: 1.168262517454618
COGS to revenue (%): 85.53099335114197
SG&A to revenue (%): 9.817405001785383
Free cash flow (dilution-adjusted): -334878000
Buyback yield (%): 0
Retained earnings: 652561000
Inventory turnover: 131.00008653513328
Receivables turnover: 1.8457322223728532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5077534791252485
FCF margin (%): -18.920430661586234
Revenue growth (%): 28.756402618007858
Rule of 40 score: 9.835971956421623
Financial ratios for AMRC — quarterly report dated 2025-03-31
Total revenue: 352829000
Gross profit: 51919000
Operating income: 13431000
Net income: -5483000
Capital expenditures: 114240000
Operating cash flow: -28304000
Depreciation & amortization: 23940000
Net tangible assets: 934422000
Owner earnings: -95783000
Return on net tangible assets (%): -10.25050780054408
Capex to operating income (%): 850.5695778423052
Buffett classification: The Gruesome
Stock price: 12.08
Shares outstanding: 34951417
Book value: 1048044000
P/B ratio: 0.40285819809091983
Market cap (USD): 422213117.36
Debt to equity: 1.7023283373598819
Current ratio: 1.5746713348908
Quick ratio: 1.5592035625481488
Interest coverage ratio: 0.6747550866616429
COGS to revenue (%): 85.28493973001086
SG&A to revenue (%): 10.908400386589538
Free cash flow (dilution-adjusted): -145388000
Buyback yield (%): 0
Retained earnings: 647051000
Inventory turnover: 24.36912860382248
Receivables turnover: 0.37865720816922266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3983526098309545
FCF margin (%): -41.206363422507785
Rule of 40 score: -41.206363422507785
Financial ratios for AMRC — quarterly report dated 2025-06-30
Total revenue: 472284000
Gross profit: 73358000
Operating income: 27624000
Net income: 15518000
Capital expenditures: 104535000
Operating cash flow: -26873000
Depreciation & amortization: 25199000
Net tangible assets: 956371000
Owner earnings: -63818000
Return on net tangible assets (%): -6.6729334118244905
Capex to operating income (%): 378.42093831450916
Buffett classification: The Gruesome
Stock price: 15.19
P/E ratio: 52.90603131340309
Shares outstanding: 34951417
Book value: 1072414000
P/B ratio: 0.4950625637393768
Market cap (USD): 530912024.22999996
Debt to equity: 1.7601224900085228
Current ratio: 1.557558616914515
Quick ratio: 1.5424882157953959
Effective tax rate (%): -22.983040101442384
Interest coverage ratio: 1.2976934279137502
COGS to revenue (%): 84.46739673586232
SG&A to revenue (%): 9.68358021868198
Free cash flow (dilution-adjusted): -135159000
Buyback yield (%): 0
Retained earnings: 659888000
Inventory turnover: 32.200016143352975
Receivables turnover: 0.5128682938271283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7953460852440326
FCF margin (%): -28.61816195340092
Revenue growth (%): 33.85634400800387
Rule of 40 score: 5.238182054602952
Financial ratios for AMRC — quarterly report dated 2025-09-30
Total revenue: 525987000
Gross profit: 84329000
Operating income: 40957000
Net income: 21840000
Capital expenditures: 81436000
Operating cash flow: 17712000
Depreciation & amortization: 27235000
Net tangible assets: 978308000
Owner earnings: -32361000
Return on net tangible assets (%): -3.307853968279928
Capex to operating income (%): 198.83292233317871
Buffett classification: The Gruesome
Stock price: 33.58
P/E ratio: 36.82097514854902
Shares outstanding: 34951417
Book value: 1095442000
P/B ratio: 1.0714109764460373
Market cap (USD): 1173668582.86
Debt to equity: 1.7781553016955713
Current ratio: 1.5122937424611334
Quick ratio: 1.4986825281406666
Effective tax rate (%): -20.251073670300627
Interest coverage ratio: 1.8568708346556648
COGS to revenue (%): 83.96747448130847
SG&A to revenue (%): 8.245831170732357
Free cash flow (dilution-adjusted): -67470000
Buyback yield (%): 0
Retained earnings: 678393000
Inventory turnover: 34.54501368791553
Receivables turnover: 0.509195267658428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1745252732132703
FCF margin (%): -12.827313222570139
Revenue growth (%): 11.370912417104963
Rule of 40 score: -1.4564008054651758
Financial ratios for AMRC — annual report dated 2025-12-31
Total revenue: 1932126000
Gross profit: 304013000
Operating income: 128557000
Net income: 56675000
Capital expenditures: 355999000
Operating cash flow: -80360000
Depreciation & amortization: 104269000
Net tangible assets: 1003384000
Owner earnings: -195055000
Return on net tangible assets (%): -19.43971600105244
Capex to operating income (%): 276.9191875977193
Buffett classification: The Gruesome
Stock price: 29.29
P/E ratio: 18.063114317247464
Shares outstanding: 34951417
Book value: 1124235000
P/B ratio: 0.9105987662099116
Market cap (USD): 1023727003.93
Debt to equity: 1.730714663749127
Current ratio: 1.50890746730527
Quick ratio: 1.4966527749700655
Effective tax rate (%): -26.014452473596446
Interest coverage ratio: 1.4619382278020379
COGS to revenue (%): 84.26536364605622
SG&A to revenue (%): 9.24039115461414
Free cash flow (dilution-adjusted): -450781000
Buyback yield (%): 0
Retained earnings: 696737000
Inventory turnover: 129.12308668411453
Receivables turnover: 1.6330617657723447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.664490610806395
FCF margin (%): -23.330828320720283
Revenue growth (%): 9.164101590573177
Rule of 40 score: -14.166726730147106
Financial ratios for AMRC — quarterly report dated 2025-12-31
Total revenue: 581026000
Gross profit: 94407000
Operating income: 46544000
Net income: 24922000
Capital expenditures: 55788000
Operating cash flow: -42895000
Depreciation & amortization: 27895000
Net tangible assets: 1003384000
Owner earnings: -2971000
Return on net tangible assets (%): -0.29609800435326855
Capex to operating income (%): 119.8607768992781
Buffett classification: The Gruesome
Stock price: 29.29
P/E ratio: 18.024314733700724
Shares outstanding: 34951417
Book value: 1124235000
P/B ratio: 0.9105987662099116
Market cap (USD): 1023727003.93
Debt to equity: 1.730714663749127
Current ratio: 1.50890746730527
Quick ratio: 1.4966527749700655
Effective tax rate (%): -33.90285837094348
Interest coverage ratio: 1.8853647668813545
COGS to revenue (%): 83.75167376330836
SG&A to revenue (%): 8.767765986375824
Free cash flow (dilution-adjusted): -102764000
Buyback yield (%): 0
Retained earnings: 696737000
Inventory turnover: 38.592989134745025
Receivables turnover: 0.4910918571147236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3267270626210386
FCF margin (%): -17.68664397118201
Revenue growth (%): 10.463946827583191
Rule of 40 score: -7.22269714359882
Financial ratios for APLD — annual report dated 2022-05-31
Total revenue: 8549000
Gross profit: -957000
Operating income: -20898000
Net income: -23520000
Capital expenditures: 54974000
Operating cash flow: -872000
Depreciation & amortization: 1120000
Net tangible assets: 72259000
Owner earnings: -77374000
Return on net tangible assets (%): -107.07870299893439
Buffett classification: The Gruesome
Stock price: 4.83
Shares outstanding: 285769539
Book value: 79235000
P/B ratio: 17.419913843251088
Market cap (USD): 1380266873.3700001
Debt to equity: 0.17093456174670285
Current ratio: 1.3918890957997103
Quick ratio: 1.3918890957997103
Interest coverage ratio: -186.58928571428572
COGS to revenue (%): 111.1942917300269
SG&A to revenue (%): 233.25535150309977
Free cash flow (dilution-adjusted): -68183000
Buyback yield (%): 0
Retained earnings: -56070000
Receivables turnover: 37.66079295154185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.969378558396166
FCF margin (%): -797.555269622178
Rule of 40 score: -797.555269622178